Scientists have uncovered a major molecular vulnerability in pancreatic cancer cells, showing that oncogenic KRAS mutations can be exploited to trigger an inflammatory form of programmed cell death.
Most Recent Articles
Restoring Cellular Energetics and Glomerular Filtration via Monoclonal ENPP1 Inhibition
A newly developed monoclonal antibody engineered to help heart tissue heal has been shown to successfully stimulate regeneration and reverse functional decline in damaged kidney tissues.
Clinical Efficacy of the Connect Me BP Digital Telemonitoring Service in Hypertension Management
A population-wide study reveals that home blood pressure telemonitoring significantly reduces long-term risks of stroke, heart attack, hospitalizations, and mortality in patients with hypertension.
Cardiac MRI Metrics of Subclinical Remodeling and Incident Cancer Risk in the MESA Cohort
A long-term study reveals that subtle, asymptomatic changes in heart structure and function detected on cardiac MRI are strongly associated with an increased risk of developing cancer years later.
Utilizing Cell-Free HDL Efflux Capacity to Predict Unstable Lipid-Rich Coronary Lesions
Researchers have validated a straightforward cell-free blood test that measures how effectively a patient's good cholesterol clears arterial walls, helping predict dangerous, rupture-prone coronary plaques.